Table of contents
Volume 85, Issue 6
Published online 11 September 2001 (785-936)
Editorial
Cancer survival differences between European populations: the UK uneasiness FREE
G Gatta, R Capocaccia and F Berrino
Br J Cancer 85: 785-786; doi:10.1054/bjoc.2001.1999
Regular Articles
Are differences in stage at presentation a credible explanation for reported differences in the survival of patients with colorectal cancer in Europe? FREE
C B J Woodman, A Gibbs, N Scott, N Y Haboubi and S Collins
Br J Cancer 85: 787-790; doi:10.1054/bjoc.2001.1958
Sentinel node procedure in Ib cervical cancer: a preliminary series FREE
T Lantzsch, M Wolters, J Grimm, T Mende, J Buchmann, G Sliutz and H Koelbl
Br J Cancer 85: 791-794; doi:10.1054/bjoc.2001.2005
Contribution of vascular endothelial growth factor to the Nottingham prognostic index in node-negative breast cancer FREE
D Coradini, P Boracchi, M Grazia Daidone, C Pellizzaro, P Miodini, M Ammatuna, G Tomasic and E Biganzoli
Br J Cancer 85: 795-797; doi:10.1054/bjoc.2001.2019
Salvage chemotherapy with high-dose leucovorin (LV) and 48-hour continuous infusion (CI) of 5-fluorouracil (5-FU) in combination with conventional doses of cyclophosphamide (CPM) in patients with metastatic breast cancer (MBC) pretreated with anthracycline and taxanes FREE
K Kalbakis, Ch Kouroussis, S Kakolyris, D Mavroudis, J Souglakos, S Agelaki, L Vamvakas, M Christodoulakis, K Stylianou and V Georgoulias
Br J Cancer 85: 798-802; doi:10.1054/bjoc.2001.2001
The relation between mortality from malignant melanoma and early detection in the Cancer Research Campaign Mole Watcher Study FREE
J Melia, S Moss, D Coleman, T Frost, R Graham-Brown, J A A Hunter, R A Marsden, A du Vivier, A P Warin, J White, S M Whitehead and M A Wroughton
Br J Cancer 85: 803-807; doi:10.1054/bjoc.2001.2012
Progress in the management and outcome of small-cell lung cancer in a French region from 1981 to 1994 FREE
M P Lebitasy, G Hédelin, A Purohit, L Moreau, F Klinzig and E Quoix
Br J Cancer 85: 808-815; doi:10.1054/bjoc.2001.1955
Identification of patients at risk for early death after conventional chemotherapy in solid tumours and lymphomas FREE
I Ray-Coquard, H Ghesquière, T Bachelot, C Borg, P Biron, C Sebban, A LeCesne, F Chauvin and J-Y Blay
Br J Cancer 85: 816-822; doi:10.1054/bjoc.2001.2011
Cisplatin neurotoxicity in the treatment of metastatic germ cell tumour: time course and prognosis FREE
M von Schlippe, C J Fowler and S J Harland
Br J Cancer 85: 823-826; doi:10.1054/bjoc.2001.2006
A polymorphism in the enhancer region of the thymidylate synthase promoter influences the survival of colorectal cancer patients treated with 5-fluorouracil FREE
B Iacopetta, F Grieu, D Joseph and H Elsaleh
Br J Cancer 85: 827-830; doi:10.1054/bjoc.2001.2007
Detection of the PAX3-FKHR fusion gene in paediatric rhabdomyosarcoma: a reproducible predictor of outcome? FREE
J Anderson, T Gordon, A McManus, T Mapp, S Gould, A Kelsey, H McDowell, R Pinkerton, J Shipley and K Pritchard-Jones (on behalf of the UK Children's Cancer Study Group (UKCCSG) and the UK Cancer Cytogenetics Group)
Br J Cancer 85: 831-835; doi:10.1054/bjoc.2001.2008
CDKN2A and CDK4 mutation analysis in Italian melanoma-prone families: functional characterization of a novel CDKN2A germ line mutation FREE
G Della Torre, B Pasini, S Frigerio, R Donghi, D Rovini, D Delia, G Peters, T J G Huot, G Bianchi-Scarra, F Lantieri, M Rodolfo, G Parmiani and M A Pierotti
Br J Cancer 85: 836-844; doi:10.1054/bjoc.2001.1991
Detection of germline BRCA1 mutations by Multiple-Dye Cleavase Fragment Length Polymorphism (MD-CFLP) method FREE
S Casadei, L Cortesi, V Pensotti, P Radice, M Pierotti, D Amadori and D Calistri
Br J Cancer 85: 845-849; doi:10.1054/bjoc.2001.1988
Mutations of the BRCA1 and BRCA2 genes in patients with bilateral breast cancer FREE
D Steinmann, M Bremer, D Rades, B Skawran, C Siebrands, J H Karstens and T Dörk
Br J Cancer 85: 850-858; doi:10.1054/bjoc.2001.2016
Catechol-O-Methyltransferase (COMT) gene polymorphism and breast cancer risk in young women FREE
M Bergman-Jungeström and S Wingren
Br J Cancer 85: 859-862; doi:10.1054/bjoc.2001.2009
Angiogenesis is an independent prognostic factor in malignant mesothelioma FREE
J G Edwards, G Cox, A Andi, J L Jones, R A Walker, D A Waller and K J O'Byrne
Br J Cancer 85: 863-868; doi:10.1054/bjoc.2001.1997
Tumour markers in breast carcinoma correlate with grade rather than with invasiveness FREE
F Wärnberg, H Nordgren, L Bergkvist and L Holmberg
Br J Cancer 85: 869-874; doi:10.1054/bjoc.2001.1995
Is there loss or qualitative changes in the expression of thyroid peroxidase protein in thyroid epithelial cancer? FREE
B Czarnocka, D Pastuszko, M Janota-Bzowski, A P Weetman, P F Watson, E H Kemp, R S McIntosh, M S Asghar, B Jarzab, E Gubala, J Wloch and D Lange
Br J Cancer 85: 875-880; doi:10.1054/bjoc.2001.2015
Relation of hypoxia inducible factor 1
and 2 in operable non-small cell lung cancer to angiogenic/molecular profile of tumours and survival FREE
A Giatromanolaki, M I Koukourakis, E Sivridis, H Turley, K Talks, F Pezzella, K C Gatter and A L Harris
Br J Cancer 85: 881-890; doi:10.1054/bjoc.2001.2018
Analysis of CC chemokine and chemokine receptor expression in solid ovarian tumours FREE
C Scotton, D Milliken, J Wilson, S Raju and F Balkwill
Br J Cancer 85: 891-897; doi:10.1054/bjoc.2001.2020
Short Communication
DNA damage-induced cell cycle checkpoints involve both p53-dependent and -independent pathways: role of telomere repeat binding factor 2 FREE
S Narayan, A S Jaiswal, A S Multani and S Pathak
Br J Cancer 85: 898-901; doi:10.1054/bjoc.2001.2002
Regular Articles
Inactivation of wild-type p53 by a dominant negative mutant renders MCF-7 cells resistant to tubulin-binding agent cytotoxicity FREE
C M Galmarini, N Falette, E Tabone, C Levrat, R Britten, N Voorzanger-Rousselot, O Roesch-Gateau, A Vanier-Viornery, A Puisieux and C Dumontet
Br J Cancer 85: 902-908; doi:10.1054/bjoc.2001.2017
The topology of plasminogen binding and activation on the surface of human breast cancer cells FREE
N M Andronicos and M Ranson
Br J Cancer 85: 909-916; doi:10.1054/bjoc.2001.2022
Sodium phenylacetate enhances the inhibitory effect of dextran derivative on breast cancer cell growth in vitro and in nude mice FREE
M Di Benedetto, Y Kourbali, A Starzec, R Vassy, J Jozefonvicz, G Perret, M Crepin and M Kraemer
Br J Cancer 85: 917-923; doi:10.1054/bjoc.2001.1993
Cell surface antigens in renal tumour cells: detection by immunoluminescence and enzymatic analysis FREE
F Laube, B Göhring, H Sann and I Willhardt
Br J Cancer 85: 924-929; doi:10.1054/bjoc.2001.2004
Hypermethylation of CpG islands in the mouse asparagine synthetase gene: relationship to asparaginase sensitivity in lymphoma cells. Partial methylation in normal cells FREE
H Peng, N Shen, L Qian, X-L Sun, P Koduru, L O Goodwin, J-P Issa and J D Broome
Br J Cancer 85: 930-935; doi:10.1054/bjoc.2001.2000
Calendar
The published online date indicates the date that the issue is published online and is the first official publication date of the issue. Each print issue of BJC is published one week after it has been published online.
